Cargando…

Basal cell carcinomas acquire secondary mutations to overcome dormancy and progress from microscopic to macroscopic disease

Basal cell carcinomas (BCCs) frequently possess immense mutational burdens; however, the functional significance of most of these mutations remains unclear. Here, we report that loss of Ptch1, the most common mutation that activates upstream Hedgehog (Hh) signaling, initiates the formation of nascen...

Descripción completa

Detalles Bibliográficos
Autores principales: Trieu, Kenneth G., Tsai, Shih-Ying, Eberl, Markus, Ju, Virginia, Ford, Noah C., Doane, Owen J., Peterson, Jamie K., Veniaminova, Natalia A., Grachtchouk, Marina, Harms, Paul W., Swartling, Fredrik J., Dlugosz, Andrzej A., Wong, Sunny Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127636/
https://www.ncbi.nlm.nih.gov/pubmed/35508126
http://dx.doi.org/10.1016/j.celrep.2022.110779
_version_ 1784712395902418944
author Trieu, Kenneth G.
Tsai, Shih-Ying
Eberl, Markus
Ju, Virginia
Ford, Noah C.
Doane, Owen J.
Peterson, Jamie K.
Veniaminova, Natalia A.
Grachtchouk, Marina
Harms, Paul W.
Swartling, Fredrik J.
Dlugosz, Andrzej A.
Wong, Sunny Y.
author_facet Trieu, Kenneth G.
Tsai, Shih-Ying
Eberl, Markus
Ju, Virginia
Ford, Noah C.
Doane, Owen J.
Peterson, Jamie K.
Veniaminova, Natalia A.
Grachtchouk, Marina
Harms, Paul W.
Swartling, Fredrik J.
Dlugosz, Andrzej A.
Wong, Sunny Y.
author_sort Trieu, Kenneth G.
collection PubMed
description Basal cell carcinomas (BCCs) frequently possess immense mutational burdens; however, the functional significance of most of these mutations remains unclear. Here, we report that loss of Ptch1, the most common mutation that activates upstream Hedgehog (Hh) signaling, initiates the formation of nascent BCC-like tumors that eventually enter into a dormant state. However, rare tumors that overcome dormancy acquire the ability to hyperactivate downstream Hh signaling through a variety of mechanisms, including amplification of Gli1/2 and upregulation of Mycn. Furthermore, we demonstrate that MYCN overexpression promotes the progression of tumors induced by loss of Ptch1. These findings suggest that canonical mutations that activate upstream Hh signaling are necessary, but not sufficient, for BCC to fully progress. Rather, tumors likely acquire secondary mutations that further hyperactivate downstream Hh signaling in order to escape dormancy and enter a trajectory of uncontrolled expansion.
format Online
Article
Text
id pubmed-9127636
institution National Center for Biotechnology Information
language English
publishDate 2022
record_format MEDLINE/PubMed
spelling pubmed-91276362022-05-24 Basal cell carcinomas acquire secondary mutations to overcome dormancy and progress from microscopic to macroscopic disease Trieu, Kenneth G. Tsai, Shih-Ying Eberl, Markus Ju, Virginia Ford, Noah C. Doane, Owen J. Peterson, Jamie K. Veniaminova, Natalia A. Grachtchouk, Marina Harms, Paul W. Swartling, Fredrik J. Dlugosz, Andrzej A. Wong, Sunny Y. Cell Rep Article Basal cell carcinomas (BCCs) frequently possess immense mutational burdens; however, the functional significance of most of these mutations remains unclear. Here, we report that loss of Ptch1, the most common mutation that activates upstream Hedgehog (Hh) signaling, initiates the formation of nascent BCC-like tumors that eventually enter into a dormant state. However, rare tumors that overcome dormancy acquire the ability to hyperactivate downstream Hh signaling through a variety of mechanisms, including amplification of Gli1/2 and upregulation of Mycn. Furthermore, we demonstrate that MYCN overexpression promotes the progression of tumors induced by loss of Ptch1. These findings suggest that canonical mutations that activate upstream Hh signaling are necessary, but not sufficient, for BCC to fully progress. Rather, tumors likely acquire secondary mutations that further hyperactivate downstream Hh signaling in order to escape dormancy and enter a trajectory of uncontrolled expansion. 2022-05-03 /pmc/articles/PMC9127636/ /pubmed/35508126 http://dx.doi.org/10.1016/j.celrep.2022.110779 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ).
spellingShingle Article
Trieu, Kenneth G.
Tsai, Shih-Ying
Eberl, Markus
Ju, Virginia
Ford, Noah C.
Doane, Owen J.
Peterson, Jamie K.
Veniaminova, Natalia A.
Grachtchouk, Marina
Harms, Paul W.
Swartling, Fredrik J.
Dlugosz, Andrzej A.
Wong, Sunny Y.
Basal cell carcinomas acquire secondary mutations to overcome dormancy and progress from microscopic to macroscopic disease
title Basal cell carcinomas acquire secondary mutations to overcome dormancy and progress from microscopic to macroscopic disease
title_full Basal cell carcinomas acquire secondary mutations to overcome dormancy and progress from microscopic to macroscopic disease
title_fullStr Basal cell carcinomas acquire secondary mutations to overcome dormancy and progress from microscopic to macroscopic disease
title_full_unstemmed Basal cell carcinomas acquire secondary mutations to overcome dormancy and progress from microscopic to macroscopic disease
title_short Basal cell carcinomas acquire secondary mutations to overcome dormancy and progress from microscopic to macroscopic disease
title_sort basal cell carcinomas acquire secondary mutations to overcome dormancy and progress from microscopic to macroscopic disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127636/
https://www.ncbi.nlm.nih.gov/pubmed/35508126
http://dx.doi.org/10.1016/j.celrep.2022.110779
work_keys_str_mv AT trieukennethg basalcellcarcinomasacquiresecondarymutationstoovercomedormancyandprogressfrommicroscopictomacroscopicdisease
AT tsaishihying basalcellcarcinomasacquiresecondarymutationstoovercomedormancyandprogressfrommicroscopictomacroscopicdisease
AT eberlmarkus basalcellcarcinomasacquiresecondarymutationstoovercomedormancyandprogressfrommicroscopictomacroscopicdisease
AT juvirginia basalcellcarcinomasacquiresecondarymutationstoovercomedormancyandprogressfrommicroscopictomacroscopicdisease
AT fordnoahc basalcellcarcinomasacquiresecondarymutationstoovercomedormancyandprogressfrommicroscopictomacroscopicdisease
AT doaneowenj basalcellcarcinomasacquiresecondarymutationstoovercomedormancyandprogressfrommicroscopictomacroscopicdisease
AT petersonjamiek basalcellcarcinomasacquiresecondarymutationstoovercomedormancyandprogressfrommicroscopictomacroscopicdisease
AT veniaminovanataliaa basalcellcarcinomasacquiresecondarymutationstoovercomedormancyandprogressfrommicroscopictomacroscopicdisease
AT grachtchoukmarina basalcellcarcinomasacquiresecondarymutationstoovercomedormancyandprogressfrommicroscopictomacroscopicdisease
AT harmspaulw basalcellcarcinomasacquiresecondarymutationstoovercomedormancyandprogressfrommicroscopictomacroscopicdisease
AT swartlingfredrikj basalcellcarcinomasacquiresecondarymutationstoovercomedormancyandprogressfrommicroscopictomacroscopicdisease
AT dlugoszandrzeja basalcellcarcinomasacquiresecondarymutationstoovercomedormancyandprogressfrommicroscopictomacroscopicdisease
AT wongsunnyy basalcellcarcinomasacquiresecondarymutationstoovercomedormancyandprogressfrommicroscopictomacroscopicdisease